Mo1872 - Adalimumab Persistence at 1 Year is Significantly Higher in an Integrated Health Care System than for Privately Insured Patients with Inflammatory Bowel Disease

2018 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []